OPAL study reaches 2,000 participants!

Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC).

Lowe DM. et al, (2027), Lancet Microbe

Multi-objective optimisation of 3D-printed multilayer TPMS osteochondral scaffolds for enhanced mechanical and biological performance

Xu Y. et al, (2026), Virtual and Physical Prototyping, 21

Association between SARS-CoV-2 and diabetes: A population-based cohort study using the UK CPRD GOLD database.

Spivakovsky P. et al, (2026), J Diabetes Metab Disord, 25

Subharmonics are not an infallible safety metric for cavitation dynamics.

Wu Q. et al, (2026), Int J Hyperthermia, 43

TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMT.

Prunotto G. et al, (2026), J Hum Immun, 2

A concise guide to setting up a germ-free unit

Binet R. and Pearson CF., (2026), STAR Protocols, 7

A nerve and mast cell sentinel system releases extracellular condensates to induce macrophage repair.

Salm L. et al, (2026), J Exp Med, 223

Awareness of human papillomavirus and oropharyngeal cancer in Australia in the setting of increasing incidence

Tang A. et al, (2026), Vaccine, 89, 128906 - 128906

Cellhub

SANSOM S., (2026)

Spatialhub

JULE A. et al, (2026)

txseq

SANSOM S., (2026)

n vitro generation of phenotypically well-defined T-cell populations using hydrogel microsphere synthetic antigen presenting cells

FRITZSCHE M. and COLIN-YORK H., (2026)

A light plane illumination microscopy-based imaging method for characterizing molecular reaction- diffusion kinetics in biology

FRITZSCHE M. and Karedla N., (2026)

Treatment

WILLIAMS R. and CLANCHY F., (2026)

A method to image tissue biopsies with a vitroscope chamber at the ZEISS Lattice Light Sheet, Oxford University Innovation

FRITZSCHE M. and Schepers A., (2026)

UTSE Lightsheet Software Technology, Cytotoxicity pipeline software for UTSE

FRITZSCHE M. and Pfannenstill V., (2026)

Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework.

Czajka-Francuz P. et al, (2026), Br J Cancer

Journal update monthly top five.

Johnstone K. et al, (2026), Emerg Med J, 43, 526 - 527

Temporal trends in epidemiology and patient characteristics of 36 cancers: a protocol for a multinational population-based cohort study using OMOP-standardised databases to investigate CANcer (OMOPCAN).

López-Sánchez I. et al, (2026), BMJ Open, 16

SECURE study: baseline findings from a UK prospective cohort of incidentally detected MGUS.

Knight E. et al, (2026), Blood Cancer J, 16

Search results

Showing results for